Related Experiment Video
Updated: Oct 9, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Egyptian practical guidance in hypertriglyceridemia management 2021
Hesham Salah El Din Taha1, Hossam Kandil2, Nabil Farag3
1Department of Cardiology, Faculty of Medicine, Cairo University, 27 Nafezet Sheem El Shafae St Kasr Al Ainy, Cairo, 11562, Egypt. heshsalt@yahoo.com.
Hypertriglyceridemia (high triglyceride levels) is common and increases cardiovascular disease risk. Managing high TG levels, especially with statins, significantly reduces vascular events and pancreatitis risk.
Area of Science:
- Cardiology
- Endocrinology
- Preventive Medicine
Background:
- Hypertriglyceridemia (HTG) is a prevalent clinical issue.
- Elevated triglyceride (TG) levels are an independent risk factor for atherosclerotic cardiovascular disease (ASCVD).
- Severe HTG poses a risk for acute pancreatitis.
Purpose of the Study:
- To provide an updated guidance on the management of HTG.
- To review causes, classification, risk estimation, diagnosis, and treatment of HTG.
- To emphasize the latest data on managing high TG levels in patients on statin therapy.
Main Methods:
- Review of current literature and guidelines on HTG management.
- Focus on lifestyle modifications, secondary cause identification, and pharmacotherapy.
- Risk stratification and diagnostic criteria for HTG.
Main Results:
- Management of high TG levels in patients on statins reduces major vascular events.
- Treatment goals include reducing ASCVD and acute pancreatitis risk.
- Current guidelines offer recommendations for HTG management strategies.
Conclusions:
- HTG requires clinical attention due to its association with ASCVD and pancreatitis.
- A multi-faceted approach including lifestyle, secondary cause management, and pharmacotherapy is essential.
- Updated guidance facilitates effective HTG management based on recent evidence.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Angina IV: Management